HitGen Inc. Company Profile

12:18 EST 25th January 2020 | BioPortfolio

HitGen is a rapidly growing biotech company with headquarter and main research facility based in Chengdu, China and with a subsidiary in the USA. HitGen has established a platform for small molecule drug discovery research centred on the design, synthesis and screening of DNA encoded chemical libraries (DELs). HitGen’s DELs contain over 400 billion novel, diverse, drug-like small molecule and macrocyclic compounds. These compounds are members of DELs synthesised from many hundreds of distinct chemical scaffolds, designed with tractable chemistry, and yielded proven results for the discovery of small molecule leads against precedented and unprecedented classes of biological targets. HitGen is collaborating with pharmaceutical, biotech, and chemical companies, foundations and research institutes in North America, Europe, Asia and Africa to discover and develop approaches for novel medicines and other solutions.

News Articles [19 Associated News Articles listed on BioPortfolio]

Gilead taps HitGen for drug discovery

Gilead and HitGen have signed a drug discovery collaboration â one of several recently announced agreements as HitGen sees increased demand for its technology, says CSO.

Chengdu's HitGen Partners with Galapagos for Drug Discovery

Chengdu HitGen formed a partnership with Galapagos NV using HitGen's drug discovery platform to identify small molecule leads for targets specified by Galapagos. HitGen, which has formed partnerships ...

HitGen Forms Drug Discovery Partnership with Gilead Sciences

Chengdu's HitGen announced a drug discovery collaboration with Gilead Sciences to identify small molecule leads against targets specified by Gilead. HitGen will use its technology platform, based on D...

Leo Pharma Licenses Novel Dermatology Molecules Discovered by HitGen

Denmark's Leo Pharma will exercise an option to develop and market a novel class of oral dermatology drugs discovered by HitGen of Chengdu. The compounds were identified by scanning HitGen’s DNA...

HitGen Collaborates with Kymera to Identify Protein Degradation Targets

HitGen, a Chengdu drug discovery company, will collaborate with Kymera Therapeutics of Cambridge, MA to identify small molecule leads for Kymera targets. Kymera is developing drug candidates that caus...

HitGen Approved for $97 Million IPO on Shanghai's STAR Board

HitGen, a Chengdu small molecule discovery company, has been approved for a $97 million IPO on Shanghai's new Science and Technology Innovation Board. HitGen has built a DNA-encoded library that conta...

HitGen Enters into DNA-Encoded Library Based Drug Discovery Research Collaboration with Gilead Sciences

HitGen Inc. today announced that it has entered into a drug discovery research collaboration with Gilead Sciences to identify potential small molecule leads against targets of int...

HitGen Announces Strategic Collaboration with Janssen to Design and Build Novel DNA-Encoded Libraries

HitGen Inc. (“HitGen”) is pleased to announce that the company has entered into a strategic collaboration with Janssen Biotech, Inc. (“Janssen”), one of the Janssen Pharmaceutical Companies o...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [3 Associated Companies listed on BioPortfolio]

HitGen Inc.

HitGen is a rapidly growing biotech company with headquarter and main research facility based in Chengdu, China and with a subsidiary in the USA. HitGen has established a platform...

HitGen Ltd.

HitGen is an innovation driven life science company with headquarters and main research facilities based in Chengdu, China and with laboratories in Houston, Texas, USA. HitGe...

NetVation DL Medicine

DL Medicine is a newly formed discovery stage company dedicated to apply emerging technologies to expedite the drug discovery process, financed by HitGen and Anlong, a healthcare ...

More Information about "HitGen Inc." on BioPortfolio

We have published hundreds of HitGen Inc. news stories on BioPortfolio along with dozens of HitGen Inc. Clinical Trials and PubMed Articles about HitGen Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of HitGen Inc. Companies in our database. You can also find out about relevant HitGen Inc. Drugs and Medications on this site too.

Quick Search

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Corporate Database Quicklinks

Searches Linking to this Company Record